Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ghigo

Showing results (411-420 of 455) with videos related to

Pageof 46
Sort By:
Minerva Endocrinologica|August 23, 2000
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarismM Procopio, M Maccario, P Savio, et al.
Endocrine|April 27, 2001
Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell deathN Filigheddu, A Fubini, G Baldanzi, et al.
Journal of Endocrinological Investigation|November 13, 2007
Ankle brachial pressure index usefulness as predictor factor for coronary heart disease in diabetic patientsM Filippella, E Lillaz, A Ciccarelli, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|September 1, 1996
Effects of phenylalanine, histidine, and leucine on basal and GHRH-stimulated GH secretion and on PRL, insulin, and glucose levels in short children. Comparison with the effects of arginineJ Bellone, M R Valetto, G Aimaretti, et al.
Panminerva Medica|May 9, 1998
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarismM Procopio, M Maccario, P Savio, et al.
Journal of Endocrinological Investigation|May 24, 2024
Effect of Cabergoline on weight and glucose metabolism in patients with acromegalyE Varaldo, N Prencipe, C Bona, et al.
European Journal of Endocrinology|November 27, 2001
Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapyJ A Janssen, F M van der Toorn, L J Hofland, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Neuroendocrine and metabolic effects of acute ghrelin administration in human obesityF Tassone, F Broglio, S Destefanis, et al.
Journal of Endocrinological Investigation|May 26, 1999
Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humansG Bisi, V Podio, M R Valetto, et al.
Journal of Endocrinological Investigation|December 17, 2008
Update on epidemiology, etiology, and diagnosis of adult growth hormone deficiencyF Prodam, L Pagano, G Corneli, et al.
Pageof 46

Showing results (411-420 of 455) with videos related to

Sort By:
Pageof 46
Minerva Endocrinologica|August 23, 2000
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarismM Procopio, M Maccario, P Savio, et al.
Endocrine|April 27, 2001
Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell deathN Filigheddu, A Fubini, G Baldanzi, et al.
Journal of Endocrinological Investigation|November 13, 2007
Ankle brachial pressure index usefulness as predictor factor for coronary heart disease in diabetic patientsM Filippella, E Lillaz, A Ciccarelli, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|September 1, 1996
Effects of phenylalanine, histidine, and leucine on basal and GHRH-stimulated GH secretion and on PRL, insulin, and glucose levels in short children. Comparison with the effects of arginineJ Bellone, M R Valetto, G Aimaretti, et al.
Panminerva Medica|May 9, 1998
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarismM Procopio, M Maccario, P Savio, et al.
Journal of Endocrinological Investigation|May 24, 2024
Effect of Cabergoline on weight and glucose metabolism in patients with acromegalyE Varaldo, N Prencipe, C Bona, et al.
European Journal of Endocrinology|November 27, 2001
Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapyJ A Janssen, F M van der Toorn, L J Hofland, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Neuroendocrine and metabolic effects of acute ghrelin administration in human obesityF Tassone, F Broglio, S Destefanis, et al.
Journal of Endocrinological Investigation|May 26, 1999
Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humansG Bisi, V Podio, M R Valetto, et al.
Journal of Endocrinological Investigation|December 17, 2008
Update on epidemiology, etiology, and diagnosis of adult growth hormone deficiencyF Prodam, L Pagano, G Corneli, et al.
Pageof 46